Archives for: September 2001, 19
Heidi, I was looking at eatwild.com today and read the following information about CLA that I thought I would pass on to you in case you had not seen it before.
"Many people take a synthetic version (CLA) that is widely promoted as a diet aid and muscle builder. New research shows that the type of CLA in the pills may have some potentially serious side effects, including promoting insulin resistance, raising glucose levels, and reducing HDL (good) cholesterol .(3)" 3. Riserus, U., P. Arner, et al. (2002). "Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome." Diabetes Care 25(9): 1516-21.
Looks like I really need to find a grass-fed meat source. Don
Hey there, John ~ I do still think that it's best to get CLA from foods, but the article raised the question in my mind of whether all CLA supps are synthetic -- I'm not sure how they're using this term. And if so, if they're all "trans10cis12 conjugated linoleic acid." I'll do some nosing around and see if I can find something useful for you, Don! best wishes ~ :-D
Hello heidi- after searching the site I have not found info regarding olive leaf extract.If you could direct me or answer a few questions,I promise to be good for at least a month...Anyway,is it considered to be ABO friendly(I am ?And if so,is it really an effective supplement for the immune system?..should it be cycled,or can it be taken indefinitely?I was thinking of cycling it with eldeberry tea during the cold/flu season.Thanks in advance for any info you may be able to give concerning this...JohnW
Hi, John! We don't have a rating for olive leaf extract (as you discovered) -- and I just checked the BT Encyclopedia, to find that it's not used in any of the protocols, nor listed in the SuppBase appendix.
With that firm knowledge in hand, I guess we can agree it's an "unknown." :-} ProBerry3 contains elderberry concentrate, and is highly recommended for keeping the flu at bay, so that's another option for you. Thanks for writing, John! :-)